Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
AstraZeneca
McKesson
McKinsey
Johnson and Johnson

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Details for Patent: 6,455,533

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 6,455,533
Title: Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
Abstract:The invention concerns pharmaceutical compositions for oral administration, comprising an active substance belonging to the family of substituted benzhydrylpiperazines and at least a cyclodextrin.
Inventor(s): Fanara; Domenico (Wanze, BE), Berwaer; Monique (Ham-sur-Heure-Nalinnes, BE), Nolf; Philippe (Brussels, BE), Vranckx; Henri (Brussels, BE), Deleers; Michel (Linkebeek, BE)
Assignee: UCB, S.A. (Brussels, BE)
Application Number:09/446,735
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation; Use;

Drugs Protected by US Patent 6,455,533

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,455,533

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Belgium9700572Jul 03, 1997
PCT Information
PCT FiledJuly 02, 1998PCT Application Number:PCT/BE98/00100
PCT Publication Date:January 14, 1999PCT Publication Number: WO99/01133

International Family Members for US Patent 6,455,533

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 224717   Start Trial
Australia 727140   Start Trial
Australia 8201598   Start Trial
Belgium 1011251   Start Trial
Brazil 9810495   Start Trial
Canada 2294783   Start Trial
China 1150900   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Dow
Boehringer Ingelheim
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.